Voxzogo Európai Unió - magyar - EMA (European Medicines Agency)

voxzogo

biomarin international limited - vosoritide - achondroplasia - kábítószerek csontbetegségek kezelésére - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.

Cabometyx Európai Unió - magyar - EMA (European Medicines Agency)

cabometyx

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - daganatellenes szerek - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Evalon Európai Unió - magyar - EMA (European Medicines Agency)

evalon

laboratorios hipra, s.a. - vakcina a kokcidiózis ellen a csirkékben - Élő parazita vakcinák, immunológikumok a madarak - csirke - az aktív immunizálására a csajok a 1 napos korban, hogy csökkentse a klinikai tünetek (hasmenés), bélrendszeri elváltozások, oocysts kimeneti kapcsolódó coccidiosis által okozott eimeria acervulina, eimeria brunetti, eimeria maxima, eimeria necatrix, eimeria tenella.